{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:40:52Z","timestamp":1776361252813,"version":"3.51.2"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The liver is the central hub of lipoprotein metabolism. A complex relationship exists between dyslipidemia and chronic liver diseases (CLDs). Recent advances in the genetics of nonalcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) exemplify the pivotal role of lipoprotein metabolism in the pathogenesis of CLD. We review these relationships in four quintessential forms of CLD: NAFLD, ALD, cholestatic liver disease and cirrhosis, with a focus on recent discoveries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>An I148\u200aM variant in patatin-like phospholipase domain-containing protein 3 (PNPLA3) and an E167K variant in transmembrane 6 superfamily 2 (TM6SF2) are major genetic risk factors for the development and progression of NAFLD. These genetic variants also increase the risk of ALD. Both PNPLA3 and TM6SF2 are involved in the hepatic assembly of very low-density lipoprotein. The discovery of these two genetic variants highlights the risk of CLD when environmental factors are combined with functional modifications in the lipoprotein metabolism pathway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The relationship between CLD and lipoprotein metabolism is reciprocal. On the one hand, the progression of CLD impairs lipoprotein metabolism; on the other hand, modifications in lipoprotein metabolism can substantially increase the risk of CLD. These relationships are at play among the most common forms of CLD affecting a significant proportion of the population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mol.0000000000000569","type":"journal-article","created":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T03:08:28Z","timestamp":1544843308000},"page":"30-36","source":"Crossref","is-referenced-by-count":16,"title":["Lipoprotein metabolism in liver diseases"],"prefix":"10.1097","volume":"30","author":[{"given":"Maria Camila","family":"Perez-Matos","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bynvant","family":"Sandhu","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Bonder","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghui Gordon","family":"Jiang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230917","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.19.6.526","article-title":"Plasma lipids and lipoproteins in liver disease","volume":"19","author":"McIntyre","year":"1978","journal-title":"Gut"},{"key":"R2-20230917","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R3-20230917","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"R4-20230917","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"key":"R5-20230917","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"R6-20230917","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"R7-20230917","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2337\/dc14-0645","article-title":"Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis","volume":"38","author":"Mackey","year":"2015","journal-title":"Diabetes Care"},{"key":"R8-20230917","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","article-title":"Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis","volume":"227","author":"DeFilippis","year":"2013","journal-title":"Atherosclerosis"},{"key":"R9-20230917","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.metabol.2004.09.002","article-title":"Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study","volume":"54","author":"Goff","year":"2005","journal-title":"Metabolism"},{"key":"R10-20230917","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.metabol.2015.10.017","article-title":"Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: the Cardiovascular Health Study","volume":"65","author":"Jiang","year":"2016","journal-title":"Metabolism"},{"key":"R11-20230917","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/hep.23094","article-title":"Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis","volume":"50","author":"Fujita","year":"2009","journal-title":"Hepatology"},{"key":"R12-20230917","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1053\/jhep.2002.32527","article-title":"Apolipoprotein synthesis in nonalcoholic steatohepatitis","volume":"35","author":"Charlton","year":"2002","journal-title":"Hepatology"},{"key":"R13-20230917","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/liv.13076","article-title":"Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease","volume":"36","author":"Jiang","year":"2016","journal-title":"Liver Int"},{"key":"R14-20230917","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7555\/JBR.32.20180045","article-title":"Nonalcoholic fatty liver disease: a narrative review of genetics","volume":"32","author":"Danford","year":"2018","journal-title":"J Biomed Res"},{"key":"R15-20230917","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/lt.21766","article-title":"Recurrent familial hypobetalipoproteinemia- induced nonalcoholic fatty liver disease after living donor liver transplantation","volume":"15","author":"Harada","year":"2009","journal-title":"Liver Transpl"},{"key":"R16-20230917","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0016-5085(19)32931-2","article-title":"Liver ultrastructure in abetalipoproteinemia: evolution of micronodular cirrhosis","volume":"67","author":"Partin","year":"1974","journal-title":"Gastroenterology"},{"key":"R17-20230917","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2010.03.039","article-title":"Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia","volume":"139","author":"Amaro","year":"2010","journal-title":"Gastroenterology"},{"key":"R18-20230917","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"R19-20230917","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"R20-20230917","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.1323785111","article-title":"TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content","volume":"111","author":"Mahdessian","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-20230917","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1074\/jbc.M116.719955","article-title":"Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins","volume":"291","author":"Smagris","year":"2016","journal-title":"J Biol Chem"},{"key":"R22-20230917","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bbalip.2017.04.004","article-title":"Depletion of TM6SF2 disturbs membrane lipid composition and dynamics in HuH7 hepatoma cells","volume":"1862","author":"Ruhanen","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"R23-20230917","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2017.02.014","article-title":"Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD","volume":"67","author":"Luukkonen","year":"2017","journal-title":"J Hepatol"},{"key":"R24-20230917","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1053\/j.gastro.2016.01.005","article-title":"Hepatic transmembrane 6 superfamily member 2 regulates cholesterol metabolism in mice","volume":"150","author":"Fan","year":"2016","journal-title":"Gastroenterology"},{"key":"R25-20230917","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/hmg\/ddx159","article-title":"Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis","volume":"26","author":"Ehrhardt","year":"2017","journal-title":"Hum Mol Genet"},{"key":"R26-20230917","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.atherosclerosis.2017.11.033","article-title":"TM6SF2: a novel target for plasma lipid regulation","volume":"268","author":"Li","year":"2018","journal-title":"Atherosclerosis"},{"key":"R27-20230917","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/hep.29021","article-title":"TM6SF2 rs58542926 impacts lipid processing in liver and small intestine","volume":"65","author":"O\u2019Hare","year":"2017","journal-title":"Hepatology"},{"key":"R28-20230917","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","article-title":"Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase","volume":"15","author":"Kumari","year":"2012","journal-title":"Cell Metab"},{"key":"R29-20230917","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1073\/pnas.1003585107","article-title":"A feed-forward loop amplifies nutritional regulation of PNPLA3","volume":"107","author":"Huang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-20230917","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2010.10.024","article-title":"Distinct regulation of adiponutrin\/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes","volume":"55","author":"Dubuquoy","year":"2011","journal-title":"J Hepatol"},{"key":"R31-20230917","doi-asserted-by":"crossref","first-page":"37085","DOI":"10.1074\/jbc.M111.290114","article-title":"Expression and characterization of a PNPLA3 protein isoform (I148\u200aM) associated with nonalcoholic fatty liver disease","volume":"286","author":"Huang","year":"2011","journal-title":"J Biol Chem"},{"key":"R32-20230917","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/hep.23812","article-title":"Patatin-like phospholipase domain-containing 3\/adiponutrin deficiency in mice is not associated with fatty liver disease","volume":"52","author":"Chen","year":"2010","journal-title":"Hepatology"},{"key":"R33-20230917","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.M011205","article-title":"Pnpla3\/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome","volume":"52","author":"Basantani","year":"2011","journal-title":"J Lipid Res"},{"key":"R34-20230917","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.29273","article-title":"The PNPLA3 variant associated with fatty liver disease (I148\u200aM) accumulates on lipid droplets by evading ubiquitylation","volume":"66","author":"BasuRay","year":"2017","journal-title":"Hepatology"},{"key":"R35-20230917","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jhep.2012.07.030","article-title":"Patatin-like phospholipase domain-containing 3 (PNPLA3) I148\u200aM (rs738409) affects hepatic VLDL secretion in humans and in vitro","volume":"57","author":"Pirazzi","year":"2012","journal-title":"J Hepatol"},{"key":"R36-20230917","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/hep.29041","article-title":"The PNPLA3 I148\u200aM variant modulates the fibrogenic phenotype of human hepatic stellate cells","volume":"65","author":"Bruschi","year":"2017","journal-title":"Hepatology"},{"key":"R37-20230917","first-page":"5212","article-title":"PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis","volume":"25","author":"Pingitore","year":"2016","journal-title":"Hum Mol Genet"},{"key":"R38-20230917","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.bbrc.2014.03.078","article-title":"Adiponutrin: a multimeric plasma protein","volume":"446","author":"Winberg","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"R39-20230917","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in >300,000 individuals","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"R40-20230917","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/MCG.0000000000000816","article-title":"Genetic determinants of circulating lipoproteins in nonalcoholic fatty liver disease","volume":"52","author":"Jiang","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"R41-20230917","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.gastro.2016.12.020","article-title":"PNPLA3, TM6SF2, and MBOAT7 genotypes and coronary artery disease","volume":"152","author":"Simons","year":"2017","journal-title":"Gastroenterology"},{"key":"R42-20230917","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/hep4.1183","article-title":"Patatin-like phospholipase domain containing 3 variants differentially impact metabolic traits in individuals at high risk for cardiovascular events","volume":"2","author":"Ruschenbaum","year":"2018","journal-title":"Hepatol Commun"},{"key":"R43-20230917","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0009-8981(85)90147-0","article-title":"Variations in HDL and VLDL levels chronic alcoholics. Influence of the degree of liver damage and of withdrawal of alcohol","volume":"148","author":"Tateossian","year":"1985","journal-title":"Clin Chim Acta"},{"key":"R44-20230917","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/0026-0495(91)90205-B","article-title":"Effect of acute intravenous alcohol on plasma lipoproteins in man","volume":"40","author":"Mishra","year":"1991","journal-title":"Metabolism"},{"key":"R45-20230917","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0021-9150(85)90040-1","article-title":"Lipoprotein fractions, lipoprotein lipase and hepatic triglyceride lipase during short-term and long-term uptake of ethanol in healthy subjects","volume":"57","author":"Schneider","year":"1985","journal-title":"Atherosclerosis"},{"key":"R46-20230917","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.metabol.2015.08.016","article-title":"Acute alcohol consumption downregulates lipoprotein lipase activity in vivo","volume":"64","author":"Zemankova","year":"2015","journal-title":"Metabolism"},{"key":"R47-20230917","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","article-title":"Alcoholic liver disease: mechanisms of injury and targeted treatment","volume":"12","author":"Louvet","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R48-20230917","doi-asserted-by":"crossref","first-page":"29342","DOI":"10.1074\/jbc.M202411200","article-title":"Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP)","volume":"277","author":"You","year":"2002","journal-title":"J Biol Chem"},{"key":"R49-20230917","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/acer.12424","article-title":"Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor alpha protects against alcoholic liver disease","volume":"38","author":"Li","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"R50-20230917","doi-asserted-by":"crossref","first-page":"G548","DOI":"10.1152\/ajpgi.00342.2011","article-title":"Activation of peroxisome proliferator-activated receptor- gamma by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice","volume":"302","author":"Sun","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R51-20230917","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008733","article-title":"Effects of repeated binge drinking on blood pressure levels and other cardiovascular health metrics in young adults: National Health and Nutrition Examination Survey","volume":"7","author":"Piano","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R52-20230917","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa022095","article-title":"Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men","volume":"348","author":"Mukamal","year":"2003","journal-title":"N Engl J Med"},{"key":"R53-20230917","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1161\/01.CIR.102.19.2347","article-title":"Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II","volume":"102","author":"De Oliveira","year":"2000","journal-title":"Circulation"},{"key":"R54-20230917","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2016.12.008","article-title":"The causal effects of alcohol on lipoprotein subfraction and triglyceride levels using a Mendelian randomization analysis: the Nagahama study","volume":"257","author":"Tabara","year":"2017","journal-title":"Atherosclerosis"},{"key":"R55-20230917","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3945\/jn.113.175315","article-title":"A lipoprotein lipase gene polymorphism interacts with consumption of alcohol and unsaturated fat to modulate serum HDL-cholesterol concentrations","volume":"143","author":"Baik","year":"2013","journal-title":"J Nutr"},{"key":"R56-20230917","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.alcohol.2011.07.002","article-title":"Interactions of the LIPG 584T polymorphism and alcohol consumption on serum lipid levels","volume":"45","author":"Liu","year":"2011","journal-title":"Alcohol"},{"key":"R57-20230917","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1530-0277.2012.01918.x","article-title":"Interactions between the apolipoprotein a1\/c3\/a5 haplotypes and alcohol consumption on serum lipid levels","volume":"37","author":"Yin","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"R58-20230917","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med"},{"key":"R59-20230917","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"R60-20230917","first-page":"72","article-title":"Lipid and lipoprotein abnormalities in alcoholic liver disease","volume":"64","author":"Sabesin","year":"1981","journal-title":"Circulation"},{"key":"R61-20230917","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0022-2275(20)38119-0","article-title":"Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of \u2018light\u2019-HDL during partial recovery","volume":"23","author":"Weidman","year":"1982","journal-title":"J Lipid Res"},{"key":"R62-20230917","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0016-5085(77)80267-9","article-title":"Abnormal plasma lipoproteins and lecithin-cholesterol acyltransferase deficiency in alcoholic liver disease","volume":"72","author":"Sabesin","year":"1977","journal-title":"Gastroenterology"},{"key":"R64-20230917","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clinbiochem.2014.08.014","article-title":"A review on lecithin:cholesterol acyltransferase deficiency","volume":"48","author":"Saeedi","year":"2015","journal-title":"Clin Biochem"},{"key":"R65-20230917","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7326\/0003-4819-48-3-471","article-title":"Jaundice, hyperlipemia and hemolytic anemia: a heretofore unrecognized syndrome associated with alcoholic fatty liver and cirrhosis","volume":"48","author":"Zieve","year":"1958","journal-title":"Ann Intern Med"},{"key":"R66-20230917","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng.488","article-title":"Variant in PNPLA3 is associated with alcoholic liver disease","volume":"42","author":"Tian","year":"2010","journal-title":"Nat Genet"},{"key":"R67-20230917","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jhep.2011.01.028","article-title":"Common polymorphism in the PNPLA3\/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease","volume":"55","author":"Trepo","year":"2011","journal-title":"J Hepatol"},{"key":"R68-20230917","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/apt.12890","article-title":"Systematic review with meta-analysis: the I148\u200aM variant of patatin-like phospholipase domain-containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosis","volume":"40","author":"Chamorro","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R69-20230917","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/jgh.12540","article-title":"PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival","volume":"29","author":"Friedrich","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"R70-20230917","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.3417","article-title":"A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"Buch","year":"2015","journal-title":"Nat Genet"},{"key":"R71-20230917","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41395-018-0118-4","article-title":"Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis","volume":"113","author":"Stickel","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R72-20230917","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1042\/bj1570401","article-title":"Investigation of the abnormal low-density lipoproteins occurring in patients with obstructive jaundice","volume":"157","author":"Kostner","year":"1976","journal-title":"Biochem J"},{"key":"R73-20230917","first-page":"172","article-title":"Lecithin-cholesterol acyltransferase and serum cholesterol esterification in obstructive jaundice","volume":"81","author":"Kepkay","year":"1973","journal-title":"J Lab Clin Med"},{"key":"R74-20230917","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"key":"R75-20230917","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/0016-5085(85)90642-0","article-title":"Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification","volume":"89","author":"Jahn","year":"1985","journal-title":"Gastroenterology"},{"key":"R76-20230917","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0021-9150(97)06108-X","article-title":"Abnormalities of serum apo A1 containing lipoprotein particles in patients with primary biliary cirrhosis","volume":"131","author":"O\u2019Kane","year":"1997","journal-title":"Atherosclerosis"},{"key":"R77-20230917","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0009-8981(95)06251-3","article-title":"Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids","volume":"248","author":"Iglesias","year":"1996","journal-title":"Clin Chim Acta"},{"key":"R78-20230917","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.atherosclerosis.2006.11.036","article-title":"Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review","volume":"194","author":"Sorokin","year":"2007","journal-title":"Atherosclerosis"},{"key":"R79-20230917","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archinte.1997.00440280120012","article-title":"Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis","volume":"157","author":"Cicognani","year":"1997","journal-title":"Arch Intern Med"},{"key":"R80-20230917","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/apt.13216","article-title":"Low-fasting triglyceride levels are associated with noninvasive markers of advanced liver fibrosis among adults in the United States","volume":"42","author":"Jiang","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R81-20230917","first-page":"863","article-title":"Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis","volume":"21","author":"Fraser","year":"1995","journal-title":"Hepatology"},{"key":"R82-20230917","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0025-6196(12)61815-1","article-title":"Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis","volume":"69","author":"Balan","year":"1994","journal-title":"Mayo Clin Proc"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00041433-201902000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T07:07:03Z","timestamp":1694934423000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041433-201902000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000569","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}